BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 19711473)

  • 1. Improvement in the routine screening performance of cytotechnologists over time: a study using rapid prescreening.
    Brimo F; Renshaw AA; Deschenes M; Charbonneau M; Auger M
    Cancer; 2009 Oct; 117(5):311-7. PubMed ID: 19711473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the significance of workload on performance of cytotechnologists in gynecologic cytology: a study using rapid prescreening.
    Deschenes M; Renshaw AA; Auger M
    Cancer; 2008 Jun; 114(3):149-54. PubMed ID: 18412150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the performance of rapid prescreening, 10% random review, and clinical risk criteria as methods of internal quality control in cervical cytopathology.
    Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
    Cancer; 2008 Jun; 114(3):165-70. PubMed ID: 18454462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved sensitivity over time with rapid prescreening in gynecologic cytology.
    Dudding N; Renshaw AA; Ellis K
    Diagn Cytopathol; 2011 Jun; 39(6):428-30. PubMed ID: 21574262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
    Arbyn M; Schenck U; Ellison E; Hanselaar A
    Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
    Renshaw AA; DeschĂȘnes M; Auger M
    Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The European aptitude test for cervical cytopathology].
    Branca M
    Pathologica; 2001 Feb; 93(1):28-33. PubMed ID: 11294016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASC/SIL ratio for cytotechnologists: A survey of its utility in clinical practice.
    Renshaw AA; Auger M; Birdsong G; Cibas ES; Henry M; Hughes JH; Moriarty A; Tench W; Wilbur DC; Elsheikh TM
    Diagn Cytopathol; 2010 Mar; 38(3):180-3. PubMed ID: 19760762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring screening skills in gynecologic cytology. Results of voluntary self-assessment.
    Plott AE; Martin FJ; Cheek SW; Yobs AR; Wood RJ
    Acta Cytol; 1987; 31(6):911-23. PubMed ID: 3425153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. French gynecologic cytology.
    Cochand-Priollet B; Vacher-Lavenu MC
    Clin Lab Med; 1999 Dec; 19(4):877-84, viii. PubMed ID: 10572721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pap test discrepancies and follow-up histology.
    Stelow EB; Skeate R; Wahi MM; Kjeldahl K; McKeon D; Larkin S; Woronzoff K; Pambuccian SE
    Diagn Cytopathol; 2003 Aug; 29(2):111-5. PubMed ID: 12889052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Renshaw A
    Cancer; 2006 Aug; 108(4):267; author reply 268. PubMed ID: 16671112
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality and liability issues with the Papanicolaou smear: the role of professional organizations in reform initiatives.
    Stanley MW
    Arch Pathol Lab Med; 1997 Mar; 121(3):321-6. PubMed ID: 9111127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual estimated sensitivity and workload for manual screening of SurePath gynecologic cytology.
    Ellis K; Renshaw AA; Dudding N
    Diagn Cytopathol; 2012 Feb; 40(2):95-7. PubMed ID: 22246923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP).
    Nielsen ML
    Arch Pathol Lab Med; 1997 Mar; 121(3):256-9. PubMed ID: 9111112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Education and training for cytopathologists. Its role in quality assurance.
    Parker JE
    Acta Cytol; 1989; 33(4):448-50. PubMed ID: 2750433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescreening policies in cervical cytology and their effect on detecting the truly positive patient.
    Kaminsky FC; Burke RJ; Haberle KR; Mullins DL
    Acta Cytol; 1995; 39(2):239-45. PubMed ID: 7887071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory use of the diagnosis "reactive/reparative" in gynecologic smears: impact of CLIA '88.
    Allen KA; Zaleski MS; Cohen MB
    Mod Pathol; 1995 Apr; 8(3):266-9. PubMed ID: 7617652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.